Roger Dmochowski led the peer-review process as the Associate Editor responsible for the paper.
Factors associated with dose escalation of fesoterodine for treatment of overactive bladder in people >65 years of age: A post hoc analysis of data from the SOFIA study
Version of Record online: 3 APR 2014
© 2014 Wiley Periodicals, Inc.
Neurourology and Urodynamics
Volume 34, Issue 5, pages 438–443, June 2015
How to Cite
Wagg, A., Darekar, A., Arumi, D., Khullar, V. and Oelke, M. (2015), Factors associated with dose escalation of fesoterodine for treatment of overactive bladder in people >65 years of age: A post hoc analysis of data from the SOFIA study. Neurourol. Urodyn., 34: 438–443. doi: 10.1002/nau.22603
Conflict of interest: A. Wagg has Received industry support for either research, speaker honoraria or consultancy from Astellas Pharma, Pfizer Ltd, PRMA Consulting (UK), SCA and Watson Pharma. A. Darekar and D. Arumi are employees of Pfizer Ltd. V. Khullar has Received industry support for either research, speaker honoraria or consultancy from Astellas Pharma, Pfizer Ltd, Takeda and Allergan M. Oelke has Received industry for either research, speaker honoraria or consultancy from Allergan, Apogepha, Astellas, Ferring, GlaxoSmithKline, Lilly, Pfizer, Recordati and Sophiris.
- Issue online: 13 JUN 2015
- Version of Record online: 3 APR 2014
- Manuscript Accepted: 10 MAR 2014
- Manuscript Received: 4 DEC 2013
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.